SMTL ID : 6w0y.1

Structure of KHK in complex with compound 6 (2-[(1~{R},5~{S})-3-[5-cyano-6-[(2~{S},3~{R})-2-methyl-3-oxidanyl-azetidin-1-yl]-4-(trifluoromethyl)pyridin-2-yl]-3-azabicyclo[3.1.0]hexan-6-yl]ethanoic acid)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.54 Å

Oligo State

homo-dimer

Ligands

2 x S6S: 2-[(1~{R},5~{S})-3-[5-cyano-6-[(2~{S},3~{R})-2-methyl-3-oxidanyl-azetidin-1-yl]-4-(trifluoromethyl)pyridin-2-yl]-3-azabicyclo[3.1.0]hexan-6-yl]ethanoic acid(Non-covalent)

S6S.1: 22 residues within 4Å: Chain A: R.123, A.239, W.240, A.241, E.242, G.244, A.245, A.259, F.260, P.261, P.262, V.265, T.268, L.269, G.270, A.271, G.272, F.275, C.297, A.300, G.301, C.304 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:A.239, A:F.275 Hydrogen bonds: A:W.240, A:G.244, A:G.244, A:F.260, A:G.270, A:A.271, A:G.272 Water bridges: A:D.273 Salt bridges: A:R.123 S6S.3: 21 residues within 4Å: Chain B: A.239, W.240, A.241, E.242, G.244, A.245, A.259, F.260, P.261, P.262, V.265, T.268, L.269, G.270, A.271, G.272, F.275, C.297, A.300, G.301, C.304 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:A.239, B:F.275, B:A.300 Hydrogen bonds: B:W.240, B:G.244, B:F.260, B:G.270, B:A.271, B:G.272 Water bridges: B:D.273

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: K.208, K.212, W.240, E.243 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:K.208, A:K.212 SO4.4: 5 residues within 4Å: Chain B: Q.53, R.93, R.94, G.308, F.309 8 PLIP interactions: 8 interactions with chain B Hydrogen bonds: B:F.309, B:D.310 Water bridges: B:R.93, B:R.93, B:R.94, B:R.94 Salt bridges: B:R.93, B:R.94 SO4.5: 6 residues within 4Å: Chain A: R.46 Chain B: L.26, L.127, H.128, R.156, K.189 4 PLIP interactions: 3 interactions with chain B, 1 interactions with chain A Salt bridges: B:H.128, B:R.156, B:K.189, A:R.46

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Futatsugi, K. et al., Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. J.Med.Chem. (2020)

Release Date

2020-09-23

Peptides

Ketohexokinase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Ketohexokinase

Related Entries With Identical Sequence